Lv3
310 积分 2023-06-29 加入
A way to resource is a big power to success.
Off-label dermatologic uses of IL-17 inhibitors
1天前
待确认
Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa
1天前
已完结
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
6天前
已关闭
Cardiac Arrest During Long-Distance Running Races
8天前
已完结
Enhancing Diagnosis of Psoriasis and Inflammatory Skin Diseases: A Spatially Aligned Multimodal Model Integrating Clinical and Dermoscopic Images
13天前
已关闭
Association of Obesity and Innate Immune Markers With Resistance to Biologic Therapy in Psoriasis
15天前
已完结
Ixékizumab
24天前
已完结
Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data
1个月前
已完结
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
1个月前
已完结
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
1个月前
已完结
皖公网安备34019202002308
